Loading...
Loading...
EDAP| Name | Value |
|---|---|
| Revenues | 11.7M |
| Cost of Revenue | 7.6M |
| Gross Profit | 4.2M |
| Operating Expense | 9.7M |
| Operating I/L | -5.6M |
| Other Income/Expense | 1.7M |
| Interest Income | 0.4M |
| Pretax | -3.9M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -3.9M |
EDAP TMS S.A. and its subsidiaries develop, produce, market, distribute, and maintain minimally invasive medical devices for urological diseases globally. The company operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment offers ultrasound guided robotic HIFU devices for prostate cancer treatment, disposables, and leasing services. The ESWL division manufactures lithotripters for urinary stones treatment and sells disposable parts. The Distribution division markets lasers, micro-ultrasound systems, and medical products from third parties, offering leasing, disposables, and maintenance services. The company serves hospitals, urology clinics, and research institutions.
